CDKN2A is a major susceptibility gene for familial atypical multiple mole melanoma syndrome (FAMMM), and FAMMM kindreds are at high risk of developing pancreatic cancer. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.